Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL8430515 | 0.97 | MAPK1 (0.35) | MAPK1ALDH1A1TAAR1LMNATSHR | |
| SCHEMBL704267 | 0.84 | — | — | |
| SCHEMBL21490665 | 0.79 | ALDH1A1 (0.54) | MAPK1ALDH1A1LMNATSHRALOX12 | |
| SCHEMBL3318941 | 0.78 | ALDH1A1 (0.36) | MAPK1ALDH1A1TAAR1LMNATSHR | |
| SCHEMBL7033571 | 0.78 | MAPK1 (0.33) | MAPK1ALDH1A1TAAR1LMNATSHR | |
| SCHEMBL5364566 | 0.78 | TAAR1 (0.41) | MAPK1ALDH1A1TAAR1LMNATSHR | |
| SCHEMBL3063901 | 0.74 | MAPK1 (0.36) | MAPK1ALDH1A1ALOX15KCNN4 | |
| SCHEMBL15147452 | 0.74 | RIPK1 (0.35) | MAPK1ALDH1A1TAAR1LMNATSHR | |
| SCHEMBL2103073 | 0.72 | TSHR (0.33) | MAPK1TSHRMAPT | |
| SCHEMBL2272708 | 0.72 | TAAR1 (0.32) | MAPK1TAAR1LMNASLC6A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169673-A1 | LIPIDIC ANALOGS OF ANTI-CANCER STEM CELL AGENT | VIRGINIA COMMONWEALTH UNIVERSITY | 2022-06-02 | — | — | US | claimed |
| EP-3934642-A1 | LIPIDIC ANALOGS OF ANTI-CANCER STEM CELL AGENT | Virginia Commonwealth University (US) | 2022-01-12 | — | — | EP | claimed |
| WO-2012151094-A2 | COMPOSITE MATERIALS FOR BATTERY APPLICATIONS | UCHICAGO ARGONNE, LLC (US) | 2012-11-08 | — | — | WO | claimed |
| US-20120282527-A1 | COMPOSITE MATERIALS FOR BATTERY APPLICATIONS | UCHICAGO ARGONNE, LLC | 2012-11-08 | — | — | US | claimed |
| US-6936537-B2 | Methods for forming low-k dielectric films | THE BOC GROUP, INC. (US) | 2005-08-30 | — | — | US | claimed |
| US-6649540-B2 | Applying on semiconductor or integrated circuit surface substituted organosilane compound precursor, wherein precursor reacts with and deposits on surface and dielectric film | THE BOC GROUP, INC. | 2003-11-18 | — | — | US | claimed |
| EP-1271634-A2 | Methods for forming low-K dielectric films | THE BOC GROUP, INC. (US) | 2003-01-02 | — | — | EP | claimed |
| US-20020192980-A1 | Methods for forming low-k dielectric films | BOC GROUP, INC., THE | 2002-12-19 | — | — | US | claimed |
| US-20020076944-A1 | Organosilane CVD precursors and their use for making organosilane polymer low-k dielectric film | BOC GROUP, INC., THE | 2002-06-20 | — | — | US | claimed |
| EP-0409399-B1 | 3-keto HMG-COA reductase inhibitors | MERCK & CO INC (US) | 1996-03-13 | — | — | EP | claimed |
| EP-0313353-B1 | MORPHOLINYL SILANES AND USE FOR CONTROL OF PLANT DISEASES CAUSED BY FUNGI | DOWELANCO (US) | 1992-06-17 | — | — | EP | claimed |
| US-5041562-A | Anticholesterol agents; therapy for arteriosclerosis | MERCK & CO., INC. (US) | 1991-08-20 | — | — | US | claimed |
| EP-0313353-A1 | Morpholinyl silanes and use for control of plant diseases caused by fungi | DOWELANCO (US) | 1989-04-26 | — | — | EP | claimed |
| JP-4342600-A | — | — | None | — | — | JP | disclosed |
| JP-8165301-A | — | — | None | — | — | JP | disclosed |
| JP-10304889-A | — | — | None | — | — | JP | disclosed |
| EP-0551771-A2 | Process for producing polysilanes | NIPPON OIL CO. LTD. (JP) | 1993-07-21 | — | — | EP | disclosed |
| JP-H04342600-A | INTERMEDIATE FOR SYNTHESIZING HCG SUGAR CHAIN | TOWA KASEI KOGYO KK | 1992-11-30 | — | — | JP | disclosed |
| US-4839388-A | ANTIULCER AGENTS; CIRCULATION AMELIORATORS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1989-06-13 | — | — | US | disclosed |
| EP-0236510-A1 | PROSTACYCLINS AND DRUGS CONTAINING THE SAME | MITSUBISHI KASEI CORPORATION (JP) | 1987-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169673-A1 | LIPIDIC ANALOGS OF ANTI-CANCER STEM CELL AGENT | SREBF1, SREBF2, CYP46A1 | MAPK1 2370/4885ALDH1A1 493/4885TAAR1 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.